Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
sitagliptin (januvia) (1 trial)
aripiprazole (abilify) (1 trial)
perphenazine (trilafon) (1 trial)
Cocaine-Related Disorders (Phase 2)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Glucose Intolerance (Phase 4)
Myocardial Ischemia (Phase 4)
Schizophrenia (Phase 2)
Trials (2 total)
Trial APIs (3 total)